Results 91 to 100 of about 6,025 (196)

Efficacy and Safety of Intravenous Tenecteplase Before Endovascular Thrombectomy for Acute Ischemic Stroke: The Multicenter, Randomized, BRIDGE‐TNK Trial Protocol

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Six randomized trials have not detected a difference between intravenous alteplase plus endovascular thrombectomy and endovascular thrombectomy alone in stroke.
Zhongming Qiu, Fengli Li, Dongjing Xie, Guangxiong Yuan, Thanh N. Nguyen, Kai Zhou, Raul G. Nogueira, Jeffrey L. Saver, Bruce C.V. Campbell, Gregory W. Albers, Hongfei Sang, Linyu Li, Yan Tian, Zhaoyou Meng, Duolao Wang, Wenjie Zi, Qingwu Yang   +16 more
doaj   +1 more source

Intravenous Thrombolysis for Minor Acute Ischemic Stroke

Academic Emergency Medicine, Volume 33, Issue 1, January 2026.
Brit Long, Michael Gottlieb
wiley   +1 more source

Agrimonia eupatoria: atividade farmacológica, interações perigosas e efeitos colaterais. [PDF]

, 2015
Nos últimos anos observa-se, a nível mundial, um aumento considerável no consumo de plantas medicinais. Segundo dados da Organização Mundial de Saúde (2002), cerca de 80% da população mundial utiliza produtos de origem natural para combater vários ...
Ribeiro, Maria Isabel
core  

Tenecteplase [PDF]

Reactions Weekly, 2020
  +6 more sources

Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis

Frontiers in Neurology
BackgroundThis retrospective observational cohort study aimed to evaluate whether tenecteplase’s use for acute ischemic stroke (AIS) has time management advantages and clinical benefits.Methods144 AIS patients treated with alteplase and 120 with ...
Yu Yao, Yuefei Wu, Xiaoqin Zhang, Chang Liu, Lingling Cai, Yisha Ying, Jianhong Yang   +6 more
doaj   +1 more source

Tenecteplase vs Reteplase in Patients with Acute ST-Elevation Myocardial Infarction: A Retrospective Cohort Study

Clinical and Applied Thrombosis/Hemostasis
Coronary artery disease is one of the leading causes of death globally. Despite the increased number of percutaneous coronary intervention (PCI) capable facilities, fibrinolytic therapy is still being utilized especially in rural areas.
Adham Mohamed PharmD, Sara Mahmoud PharmD, Amr M. Fahmi PhD, Ahmed Mahfouz MSc, Tayseer Kanaan MD, Jihad Jaber MD, Mansour Alkhawi MD, Saleh Alkhalaf MD, Hassan Kodimi MD, Ahmed Shaaban MD, Omar Alshibli MD, Awad Almasalmeh MD, Salaheddin Arafa MD, Salah Elbdri MD, Suhail Falah MD, Fayez Altrad MD, Ezeldin Soaly MD, Rasha Elenany PharmD, Sumaya Alyafei PharmD, Abdul Rahman Arabi MD   +19 more
doaj   +1 more source

Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The aim of this study was to investigate the efficacy and safety of tenecteplase versus alteplase in patients with acute ischemic stroke, considering their diabetes history and admission hyperglycemia status.
Huihui Liu, Aoming Jin, Yuesong Pan, Xia Meng, Hao Li, Zixiao Li, Yongjun Wang, Shuya Li   +7 more
doaj   +1 more source

Thrombolysis for acute ischaemic stroke with tenecteplase in a developing country: challenges and experience from a prospective observational study

Egyptian Journal of Neurosurgery
Context This study will emphasise the importance of Tenecteplase being ideally suited as a first-choice drug for thrombolysis in AIS in developing countries, considering the numerous challenges which are faced in these parts of the world.
Neeraj Basantani, Vijay Kumar Gupta, Sanjay Kumar, Amit Narang   +3 more
doaj   +1 more source

Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke

Emergency Care and Medicine
Background/Objectives: This study aims to compare the safety of tenecteplase versus alteplase for acute ischemic stroke. Methods: This was a multicenter, retrospective cohort study including 11 Memorial Hermann Health System hospitals in Houston from 7 ...
Salma Guerrero Miranda, Ifoma Ofoegbuna, Maicuc Tran, Ada Selina Jutba, Christine Vo   +4 more
doaj   +1 more source

Humoral markers of endothelial dysfunction and systemic inflammatory response in patients with acute myocardial infarction depending on genes polymorphism of ACE (I/D) and eNOS (894G>T) [PDF]

, 2014
The dynamics of endothelial dysfunction (ED) humoral factors: a soluble form of vascular cell adhesion molecule 1 (sVCAM-1), total NO metabolites and systemic inflammatory response - C-reactive protein (CRP) in patients with acute myocardial infarction
Biryuk, I.G., Makoviychuk, I., Sydorchuk, A., Sydorchuk, L.P., Trutiak, V., Ursuliak, U.V.   +5 more
core